Crystallography Open Database

Result: there are 51 entries in the selection

Switch to the old layout of the page

Download all results as: list of COD numbers | list of CIF URLs | data in CSV format | archive of CIF files (ZIP)

Searching journal of publication like 'Molecular Pharmaceutics' volume of publication is 12

Blue left arrow Blue left arrow First | Blue left arrow Previous 20 | of 3 | Next 20 Right arrow | Last Right arrow Right arrow | Display 5 20 50 100 200 300 500 1000 entries per page

COD ID Blue up arrow Links Formula Up arrow Space group Up arrow Cell parameters Cell volume Up arrow Bibliography
1547442 CIFC11 H12 N4 O2 SP b c a9.107; 11.5902; 22.8593
90; 90; 90
2412.84Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben
Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics
Molecular Pharmaceutics, 2015, 12, 3735-3748
1547443 CIFC11 H12 N4 O2 SP b c a9.1066; 11.5983; 22.8627
90; 90; 90
2414.78Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben
Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics
Molecular Pharmaceutics, 2015, 12, 3735-3748
1547444 CIFC11 H12 N4 O2 SP b c a9.1158; 11.6222; 22.8715
90; 90; 90
2423.14Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben
Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics
Molecular Pharmaceutics, 2015, 12, 3735-3748
1547445 CIFC11 H12 N4 O2 SP b c a9.12; 11.6339; 22.8697
90; 90; 90
2426.5Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben
Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics
Molecular Pharmaceutics, 2015, 12, 3735-3748
1547446 CIFC11 H12 N4 O2 SP b c a9.1237; 11.6442; 22.8738
90; 90; 90
2430.07Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben
Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics
Molecular Pharmaceutics, 2015, 12, 3735-3748
1547447 CIFC11 H12 N4 O2 SP b c a9.128; 11.6579; 22.8759
90; 90; 90
2434.3Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben
Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics
Molecular Pharmaceutics, 2015, 12, 3735-3748
1547448 CIFC11 H12 N4 O2 SP b c a9.1311; 11.6667; 22.88
90; 90; 90
2437.4Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben
Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics
Molecular Pharmaceutics, 2015, 12, 3735-3748
1547449 CIFC11 H12 N4 O2 SP b c a9.1357; 11.6782; 22.8834
90; 90; 90
2441.4Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben
Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics
Molecular Pharmaceutics, 2015, 12, 3735-3748
1547450 CIFC11 H12 N4 O2 SP b c a9.1405; 11.6923; 22.8838
90; 90; 90
2445.67Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben
Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics
Molecular Pharmaceutics, 2015, 12, 3735-3748
1547451 CIFC11 H12 N4 O2 SP b c a9.1415; 11.7002; 22.8837
90; 90; 90
2447.58Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben
Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics
Molecular Pharmaceutics, 2015, 12, 3735-3748
1547452 CIFC11 H12 N4 O2 SP b c a9.1445; 11.713; 22.8862
90; 90; 90
2451.33Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben
Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics
Molecular Pharmaceutics, 2015, 12, 3735-3748

Blue left arrow Blue left arrow First | Blue left arrow Previous 20 | of 3 | Next 20 Right arrow | Last Right arrow Right arrow | Display 5 20 50 100 200 300 500 1000 entries per page

Back to the search form
Your own data is not in the COD? Deposit it, thanks!